FI803957L - Anticancerkinazolinderivater - Google Patents

Anticancerkinazolinderivater

Info

Publication number
FI803957L
FI803957L FI803957A FI803957A FI803957L FI 803957 L FI803957 L FI 803957L FI 803957 A FI803957 A FI 803957A FI 803957 A FI803957 A FI 803957A FI 803957 L FI803957 L FI 803957L
Authority
FI
Finland
Prior art keywords
anticancerkinazolinderivater
Prior art date
Application number
FI803957A
Other languages
English (en)
Other versions
FI76791C (fi
FI76791B (fi
Inventor
Terence Richard Jones
Kenneth Reginald Harrap
Alan Hilary Calvert
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Publication of FI803957L publication Critical patent/FI803957L/fi
Application granted granted Critical
Publication of FI76791B publication Critical patent/FI76791B/fi
Publication of FI76791C publication Critical patent/FI76791C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
FI803957A 1979-12-19 1980-12-18 Foerfarande foer framstaellning av 2-amino-4-hydroxikinazolinderivat med anticanceraktivitet. FI76791C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB7943715 1979-12-19
GB7943715 1979-12-19
GB8006813 1980-02-28
GB8006813 1980-02-28

Publications (3)

Publication Number Publication Date
FI803957L true FI803957L (fi) 1981-06-20
FI76791B FI76791B (fi) 1988-08-31
FI76791C FI76791C (fi) 1988-12-12

Family

ID=26273917

Family Applications (1)

Application Number Title Priority Date Filing Date
FI803957A FI76791C (fi) 1979-12-19 1980-12-18 Foerfarande foer framstaellning av 2-amino-4-hydroxikinazolinderivat med anticanceraktivitet.

Country Status (17)

Country Link
US (2) US4447608A (fi)
EP (1) EP0031237B1 (fi)
AU (1) AU543237B2 (fi)
CA (1) CA1184900A (fi)
DE (1) DE3069468D1 (fi)
DK (1) DK157019C (fi)
ES (3) ES497884A0 (fi)
FI (1) FI76791C (fi)
GB (1) GB2065653B (fi)
GR (1) GR72847B (fi)
HU (1) HU193505B (fi)
IE (1) IE51188B1 (fi)
IL (1) IL61756A (fi)
NO (1) NO154919C (fi)
NZ (1) NZ195876A (fi)
PT (1) PT72232B (fi)
YU (1) YU321180A (fi)

Families Citing this family (73)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927828A (en) * 1985-03-08 1990-05-22 The Trustees Of Princeton University Diastereoisomeric tetrahydropyrido-(2,3,d) pyrimidine derivatives
US5026851A (en) * 1985-03-08 1991-06-25 The Trustees Of Princeton University Pyrido[2,3-]pyrimidine derivatives
US4684653A (en) * 1985-03-08 1987-08-04 The Trustees Of Princeton University Pyrido(2,3-d)pyrimidine derivatives
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US5187167A (en) * 1986-03-27 1993-02-16 Imperial Chemical Industries Plc Pharmaceutical compositions comprising quinazolin-4-one derivatives
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4833145A (en) * 1986-06-30 1989-05-23 The Trustees Of Princeton University 4(3H)-oxo-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine derivatives
US4902796A (en) * 1986-10-20 1990-02-20 The Trustees Of Princeton University 6-alkenyl and ethynyl derivatives of 2-amino-4-hydroxypyrido[2,3-d]pyrimidines
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
JP2830008B2 (ja) * 1988-04-01 1998-12-02 武田薬品工業株式会社 縮合ピリミジン誘導体
US5223620A (en) * 1988-04-01 1993-06-29 Takeda Chemical Industries, Ltd. Pyrido[2,3-d]pyrimidine compounds useful as intermediates
GB8809978D0 (en) * 1988-04-27 1988-06-02 Ici Plc Anti-tumour agents
EP0365763A1 (en) * 1988-09-30 1990-05-02 Agouron Pharmaceuticals, Inc. Antiproliferative cyclic compounds
US5252573A (en) * 1988-12-15 1993-10-12 Imperial Chemical Industries Plc Anti-tumor agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
US4996206A (en) * 1989-12-11 1991-02-26 The Trustees Of Princeton University N-(pyrrolo[2,3-d]pyrimidin-3-ylacyl)-glutamic acid derivatives
US5160727A (en) * 1990-02-13 1992-11-03 Warner-Lambert Company Tumor cell sensitization method using quinazolinedione derivatives
US5286726A (en) * 1990-04-12 1994-02-15 The Regents Of The University Of Michigan Difluoroglutamic acid conjugates with folates and anti-folates for the treatment of neoplastic diseases
AU640016B2 (en) * 1990-05-30 1993-08-12 Imperial Chemical Industries Plc Hydroquinazoline derivatives
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9105771D0 (en) * 1991-03-19 1991-05-01 Cancer Res Inst Royal Anti-cancer compounds
US5145854A (en) * 1991-11-27 1992-09-08 Nair Madhavan G 1-formyl-5,8,10-trideazafolates
GB9205320D0 (en) * 1992-03-11 1992-04-22 Ici Plc Anti-tumour compounds
GB9205907D0 (en) * 1992-03-18 1992-04-29 Cancer Res Inst Royal Anti-cancer compounds
US5430148A (en) * 1992-03-31 1995-07-04 Agouron Pharmaceuticals, Inc. Antiproliferative quinazolines
CH684644A5 (de) * 1992-07-13 1994-11-15 Eprova Ag 5,10-Methylentetrahydrofolsäure-Cyclodextrin-Einschlussverbindungen.
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
AU693143B2 (en) * 1993-12-06 1998-06-25 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
US5821231A (en) * 1993-12-06 1998-10-13 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using same
CA2177840A1 (en) * 1993-12-06 1995-06-15 Thomas S. Arrhenius Cs-1 peptidomimetics, compositions and methods of using the same
US5770573A (en) * 1993-12-06 1998-06-23 Cytel Corporation CS-1 peptidomimetics, compositions and methods of using the same
US5804396A (en) * 1994-10-12 1998-09-08 Sugen, Inc. Assay for agents active in proliferative disorders
US5837524A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polynucleotide products
US5837815A (en) * 1994-12-15 1998-11-17 Sugen, Inc. PYK2 related polypeptide products
CA2222545A1 (en) * 1995-06-07 1996-12-19 Sugen, Inc. Quinazolines and pharmaceutical compositions
US5593999A (en) * 1995-06-07 1997-01-14 Nair; Madhavan G. Non-classical folate analogue inhibitors of glycinamide ribonucleotide formyltransferase (GARFT)
US7119174B2 (en) * 1995-12-18 2006-10-10 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
US6716575B2 (en) 1995-12-18 2004-04-06 Sugen, Inc. Diagnosis and treatment of AUR1 and/or AUR2 related disorders
WO1998026054A2 (en) * 1996-12-11 1998-06-18 Sugen, Inc. Pyk2 related products and methods
US6818440B2 (en) * 1997-04-28 2004-11-16 Sugen, Inc. Diagnosis and treatment of alk-7 related disorders
US6228641B1 (en) 1997-05-20 2001-05-08 Sugen, Inc. Diagnosis and treatment of PTP04 related disorders
US7115710B2 (en) * 1997-06-11 2006-10-03 Sugen, Inc. Diagnosis and treatment of PTP related disorders
US6342593B1 (en) 1997-06-11 2002-01-29 Sugen, Inc. Diagnosis and treatment of ALP related disorders
US6388063B1 (en) * 1997-06-18 2002-05-14 Sugen, Inc. Diagnosis and treatment of SAD related disorders
AU2237899A (en) 1998-01-21 1999-08-09 Sugen, Inc. Human orthologues of wart
EP1073723B1 (en) * 1998-04-14 2005-08-17 Sugen, Inc. Ste20-related protein kinases
US6861442B1 (en) * 1998-12-30 2005-03-01 Sugen, Inc. PYK2 and inflammation
GB9904275D0 (en) 1999-02-24 1999-04-21 Cancer Res Campaign Tech Anti-cancer compounds
US6476075B1 (en) 1999-09-23 2002-11-05 G.D. Searle & Co. Use of substituted N, N-bis-benzyl aminoalcohol compounds inhibiting cholesteryl ester transfer protein activity
US6677382B1 (en) 1999-09-23 2004-01-13 Pharmacia Corporation Substituted N,N-bis-phenyl aminoalcohol compounds useful for inhibiting cholesteryl ester transfer protein activity
US6544974B2 (en) 1999-09-23 2003-04-08 G.D. Searle & Co. (R)-chiral halogenated substituted fused heterocyclic amino compounds useful for inhibiting cholesteryl ester transfer protein activity
JP2003512838A (ja) 1999-10-22 2003-04-08 ファルマシア・アンド・アップジョン・カンパニー ショウジョウバエｇタンパク質結合レセプター、核酸、およびそれに関連する方法。
US7364866B2 (en) * 1999-10-22 2008-04-29 Pharmacia & Upjohn Company Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
US20030162223A1 (en) * 1999-10-22 2003-08-28 Lowery David E. Drosophila G protein coupled receptors, nucleic acids, and methods related to the same
US20030082534A1 (en) * 1999-11-16 2003-05-01 Peter Lind Novel G protein-coupled receptors
AU784543B2 (en) * 1999-11-16 2006-04-27 Pharmacia & Upjohn Company Novel G protein-coupled receptors
US6143776A (en) * 2000-02-02 2000-11-07 Sunesis Pharmaceuticals, Inc. Tosylproline analogs as thymidylate synthase inhibitors
WO2001062797A2 (en) * 2000-02-23 2001-08-30 Pharmacia & Upjohn Company G protein-coupled receptors
US20030027308A1 (en) * 2000-05-30 2003-02-06 Sugen Incorporated Novel human protein phosphatases identified from genomic sequencing
CA2321345A1 (fr) * 2000-10-02 2002-04-02 Abdelbast Guerfi Utilisation du graphite dans un composite pour reduire l'accumulation de glace
US20040157306A1 (en) * 2000-11-13 2004-08-12 Sugen Incorporated Mammalian protein phosphatases
US20050069976A1 (en) * 2001-02-14 2005-03-31 Peter Lind Protein-coupled receptor
PT1420809E (pt) 2001-08-31 2012-01-03 Btg Int Ltd Utilização de derivados de ciclopenta[g]quinazolina para tratamento de cancro
KR20100043294A (ko) 2001-08-31 2010-04-28 비티지 인터내셔널 리미티드 항암제로서 사용되는 시클로펜타[ｇ]퀴나졸린 화합물
WO2003042390A1 (en) * 2001-11-13 2003-05-22 Sugen, Inc. Mammalian protein phosphatases
US7537774B2 (en) * 2005-12-23 2009-05-26 Orion Therapeautics, Llc Therapeutic formulation
JP2010511382A (ja) * 2006-12-01 2010-04-15 エージェンシー フォー サイエンス，テクノロジー アンド リサーチ 癌関連タンパク質キナーゼ
AU2008237934B2 (en) 2007-04-11 2014-03-27 Merck & Cie 18F-labelled folates
US8273617B2 (en) 2009-09-30 2012-09-25 Suvolta, Inc. Electronic devices and systems, and methods for making and using the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1021196A (en) * 1964-02-20 1966-03-02 Parke Davis & Co Novel amino acids and means for producing the same
US3471498A (en) * 1967-08-11 1969-10-07 Parke Davis & Co Certain n-p-((2,4-diamino-6-quinazolinyl)-methyl)benzoylamino acids

Also Published As

Publication number Publication date
US4447608A (en) 1984-05-08
IL61756A0 (en) 1981-01-30
PT72232A (en) 1981-01-01
ES508453A0 (es) 1983-09-01
IL61756A (en) 1987-02-27
DE3069468D1 (en) 1984-11-22
GB2065653A (en) 1981-07-01
ES8308314A1 (es) 1983-09-01
IE51188B1 (en) 1986-10-29
DK157019B (da) 1989-10-30
FI76791C (fi) 1988-12-12
EP0031237B1 (en) 1984-10-17
ES508454A0 (es) 1983-08-01
AU543237B2 (en) 1985-04-04
NZ195876A (en) 1983-11-18
CA1184900A (en) 1985-04-02
YU321180A (en) 1983-06-30
GR72847B (fi) 1983-12-07
ES8300716A1 (es) 1982-11-01
NO154919B (no) 1986-10-06
NO803868L (no) 1981-06-22
GB2065653B (en) 1983-03-09
ES8307762A1 (es) 1983-08-01
ES497884A0 (es) 1982-11-01
DK540080A (da) 1981-06-20
IE802672L (en) 1981-06-19
DK157019C (da) 1990-03-26
NO154919C (no) 1987-01-14
PT72232B (en) 1981-11-02
EP0031237A1 (en) 1981-07-01
FI76791B (fi) 1988-08-31
US4564616A (en) 1986-01-14
AU6549580A (en) 1981-06-25
HU193505B (en) 1987-10-28

Similar Documents

Publication Publication Date Title
FI803957L (fi) Anticancerkinazolinderivater
FI812463L (fi) Behaollare
SE8005246L (sv) Blindnit
AT363172B (de) Markhoehlennagel
AT359315B (de) Mikrohaertepruefer
FI800725A (fi) Foerflyttningsanordning
DK163815C (da) 3-brom-4-fluor-benzaldehyd
AT369471B (de) Verbandsmauerwerk
FI802197A (fi) Huvudstoed foer behandlingsstol
AT383864B (de) Raffstore
IT1141908B (it) Diervati prostaglandinici
FI803934L (fi) Tryckkaensligt uppteckningsmaterial
FI800889A (fi) Kefalosporinantibiotika
ATA731679A (de) Haldenraeumgeraet
IT1131777B (it) Colecalciferol-derivat
SE8001389L (sv) Mobel
AT364180B (de) Diaraehmchen
FI800061A (fi) Klorbensyl-fenoxi-alkoxyl-foereningar
FI811707L (fi) Vaermeaotervinnings- och -avlaegsningsanordning
FI800503A (fi) Dea-steroider
PT71316A (pt) Nahmaschine
AT363830B (de) Schipresse
FI65885B (fi) Planteringsanordning
AT367710B (de) Gaerfuttersilo
AT371994B (de) Pelotte

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: NATIONAL RESEARCH DEVELOPMENT